Mid January the Toxins 2024 congress was held at the Estrel Conference Center in Berlin in Germany. The conference was a great success with over 1200 participants from 59 countries.
Executive Director of Dystonia Europe, Monika Benson, took part as the only non-profit organization. With a small table with information material in the exhibition hall she met with physicians from various countries and shared information on Dystonia Europe and our activities.
Monika Benson and Prof Brigitte Girard
There were plenty of presentations for the participants to choose from and some of them on the various forms of dystonia and its treatments.
Dystonia and pain was discussed in one session and the efficacy of botulinum toxin treatment. Another session was on the trial results of the long-lasting botulinum toxin daxibotulinum, which was FDA approved last year in the US for treatment of Cervical Dystonia. Read more here:
This congress is organized every other year and is all about the botulinum toxin treatment. Main sponsors of the event were Ipsen, Merz and AbbVie.
Monika Benson, Executive Director,
Dystonia Europe
